Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms

Objective—We aimed to evaluate prospectively whether patients with normal coronary angiogram but abnormal epicardial vasoreactivity to cold pressor test (CPT) are at increased risk for cardiovascular events. Methods and Results—Vasoreactivity in response to CPT and dilation of epicardial arteries to intracoronary application of nitroglycerin were assessed quantitatively (percent change of luminal area, &Dgr;LA%) in 130 patients with normal coronary angiograms. Cardiovascular events (cardiovascular death, acute coronary syndrome, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary bypass grafting, ischemic stroke, or peripheral revascularization) were assessed as clinical outcome parameters over a mean follow-up period of 45±9 months. Based on their vascular responses to CPT, patients were assigned into the following 3 groups: group 1, patients with normal vasodilator response (&Dgr;LA >0%; n=37); group 2, patients with moderate vasoconstrictor response (&Dgr;LA between 0% and −15%; n=42); and group 3, patients with severe vasoconstrictor response (&Dgr;LA ≤−15%; n=51). Although patients from groups 2 and 3 had significantly increased vasoconstrictor response to CPT (group 2, &Dgr;LA −6±3% and group 3, &Dgr;LA −24±6% versus group 1, &Dgr;LA 11±9%;P ≤0.0001), they showed normal endothelial-independent epicardial vasodilation to intracoronary application of nitroglycerin similar to patients from group 1 (&Dgr;LA 39±16% and 34±14% versus 41±14%;P =NS, respectively). During follow-up, none of the patients from group 1 developed cardiac events. However, 7 cardiovascular events occurred in group 2 and 30 occurred in group 3 in 4 and 22 patients, respectively (P ≤0.0001, univariate by log-rank test). After adjustment for known risk factors for coronary artery disease, impaired epicardial coronary vasoreactivity to CPT remained significantly associated with the risk of developing cardiovascular events (P =0.040, multivariate by Cox regression model). Conclusions—In patients with normal coronary angiogram, abnormal vasoreactivity of epicardial coronary arteries in response to sympathetic stimulation is associated with the risk of developing cardiovascular events.

[1]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[2]  P. Ridker,et al.  C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[4]  E. Escobar Hypertension and coronary heart disease , 2002, Journal of Human Hypertension.

[5]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[6]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[7]  G. Lowe,et al.  C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study: Are Inflammation and Fibrin Turnover Linked in Pathogenesis? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[8]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[9]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[10]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[11]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[12]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[13]  J. Murray,et al.  ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. , 1999, Journal of the American College of Cardiology.

[14]  M. Büchi,et al.  Effects of calcium antagonism and HMG-coenzyme reductase inhibition on endothelial function and atherosclerosis : rationale and outline of the ENCORE trials , 1999 .

[15]  J. Deanfield,et al.  Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. , 1998, Journal of the American College of Cardiology.

[16]  Griendling Kk,et al.  Oxidative stress and cardiovascular disease. , 1997 .

[17]  R. Gibbons,et al.  Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.

[18]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[19]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[20]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[21]  H. Drexler,et al.  Endothelial dysfunction: clinical implications. , 1997, Progress in cardiovascular diseases.

[22]  J. Zamorano,et al.  Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. , 1996, European heart journal.

[23]  G. B. John Mancini,et al.  Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .

[24]  T. Lüscher,et al.  Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.

[25]  A. Zeiher,et al.  Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. , 1995, Circulation.

[26]  A. Tajik,et al.  Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. , 1995, Journal of the American College of Cardiology.

[27]  A. Zeiher,et al.  Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. , 1995, Circulation.

[28]  P A Poole-Wilson,et al.  Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. , 1995, Journal of the American College of Cardiology.

[29]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[30]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[31]  A. Heagerty,et al.  Hyperlipidaemia, hypertension, and coronary heart disease , 1995, The Lancet.

[32]  A. Tajik,et al.  Erratum: Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound (J. Am. Coll. Cardiol. (1995) 26 (41-49)) , 1995 .

[33]  Garvin Aa,et al.  Myocardial perfusion imaging using single-photon emission computed tomography. , 1994 .

[34]  E. Garcia,et al.  Myocardial perfusion imaging using single-photon emission computed tomography. , 1994, American journal of cardiac imaging.

[35]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[36]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[37]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[38]  A. Yeung,et al.  The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.

[39]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[40]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[41]  H. Drexler,et al.  Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. , 1989, Journal of the American College of Cardiology.

[42]  E. Nabel,et al.  Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. , 1988, Circulation.